Summary of Market Information: The global market for Pulmonary Arterial Hypertension (PAH) reached a valuation of USD 6.02 billion in 2018 and is projected to attain USD 9.27 billion by 2026, exhibiting a Compound Annual Growth Rate (CAGR) of 5.6%. PAH is a rare and progressive disorder characterized by elevated blood pressure in the pulmonary […]
